GW & Wade’s Corteva CTVA Stock Holding History

GW & Wade’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,112	Closed	-$210K	–	422
2023 Q3	$210K	Buy	4,112 +509	+14%	+$27K	0.01%	378
2023 Q2	$206K	Buy	3,603 +24	+0.7%	+$1.4K	0.01%	364
2023 Q1	$216K	Buy	3,579 +88	+3%	+$5.38K	0.01%	351
2022 Q4	$205K	Buy	+3,491	New	+$221K	0.01%	364

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

GW & Wade's CTVA Position: Q4 2023 in Review

GW & Wade sold out of Corteva (CTVA) in Q4 2023, closing a stake of 4,112 shares — an estimated $210K sold.

GW & Wade first reported a position in CTVA in Q4 2022 and held it in 4 quarters. The position peaked at $216K in Q1 2023. 1,232 funds tracked by Wall St. Rank hold CTVA as of Q4 2023.

GW & Wade reported no remaining Corteva position as of Q4 2023 after selling out during the quarter.
GW & Wade sold 4,112 Corteva shares in Q4 2023, an estimated $210K.
GW & Wade first reported a position in Corteva in Q4 2022 and held it in 4 quarters.
GW & Wade's Corteva position peaked at $216K in Q1 2023.
1,232 funds tracked by Wall St. Rank held Corteva as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.